Triamcinolone acetonide extended-release injectable suspension (TA-ER) is associated with reduced blood glucose elevation vs. standard triamcinolone in type 2 diabetes mellitus patients with knee osteoarthritis: a randomized, blinded, parallel-group study. (April 2018) - Conaghan, P.G.; Russell, S.J.; Sala, R.; Habib, G.; Vo, Q.; Manning, R.; Kivitz, A.; Davis, Y.; Lufkin, J.; Johnson, J.R.; Kelley, S.